retatrutide phase 2 trial obesity triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18





























